Rosetta Inpharmatics, Inc. Company Profile | Company Information

afukakuja.wordpress.com
Rosetta Inpharmatics LLC, a wholly owned subsidiarg of Merck & Co. Inc., develops and implements technologies that will improvesdrug discovery. The company's leading-edge genomic researchj and data analysis efforts focus on how medicalo compoundsaffect biology, enablinv more accurate selection of drug targets and more efficientf drug development. Rosetta Inpharmatics was founded in 1996 to designb and implement DNA microarray geneexpressioj technologies. The company was establishedc with the goal to overcome the probleme limiting the discovery and effective development of pharmaceutical andagricultural products. The founders Stephen H. Friend, M.D., Ph.D., the company's Leland Hartwell, Ph.
D., and Leroy Hood, M.D., Rosetta Inpharmatics' technology and patent portfolio were enhancex by its purchase ofAcacia Biosciences, Inc. in February 1999, a companyy founded by Jasper Rine, Ph.D. In October 1999, the Company signesd a strategic partnership agreement with Agilent Technologiexs to further develop and commercializeRosetta Inpharmatics' DNA microarrays. As part of this Agilent made a significant equity investment inRosett Inpharmatics. In June 2000, Rosetta Inpharmatics successfullhy deployed its first commercially availablebioinformaticds system, the Rosetta ResolverA Gene Expression Data Analysias System.
The Rosetta Resolver system was introduced to meet the demanedfor high-level gene expression analysis withib the life sciences...